News

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
Novavax Inc. (NASDAQ:NVAX) reported first-quarter 2025 sales of $667 million, compared to $94 million a year ago, beating the ...
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Combined flu and COVID vaccine shows strong immune response in older adults
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Novavax rises after massive Q1 beat, guidance raise
Novavax (NVAX) stock jumps 35% as the company raises its 2025 revenue outlook and its Q1 2025 financials surpasses forecasts ...
COVID vaccine boosters called into question by FDA chief: ‘Void of data’
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
RFK Jr. takes aim at COVID shots for kids, worrying vaccine experts
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsLuis Sanay - Vice President, Investor ...
The Washington Post10d
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax's COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is ...